Faster aspart tied to better glycemic control than insulin aspart for gestational diabetes
Kerala:A study published in Current Diabetes Reviews has concluded that, in women with gestational diabetes, Faster aspart is associated with better glycemic control when compared to insulin aspart.
Faster aspart, a fast-acting insulin aspart, has been approved in several countries for use in pregnancy. However, there needs to be more data related to outcomes in pregnancy, efficacy and safety in the Indian population (gestational diabetes women).
Against the above background, Aneesh Ghosh did a retrospective study to compare and evaluate the safety and efficacy of faster aspart and insulin aspart for managing gestational diabetes in pregnant women.
The conclusive study points are:
·The medical records of 60 pregnant gestational diabetes women were analyzed.
·These women were treated with faster aspart or insulin aspart at a tertiary care centre (March 2019 - September 2020).
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.